Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patients.

Keir R, Evans ND, Hutchison CA, Vigano MR, Stella A, Fabbrini P, Storr M, Chappell MJ.

Comput Methods Programs Biomed. 2014 May;114(3):e29-38. doi: 10.1016/j.cmpb.2013.07.017. Epub 2013 Aug 14.

PMID:
24008249
2.

High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series.

Heyne N, Guthoff M, Krieger J, Haap M, Häring HU.

Nephron Clin Pract. 2012;121(3-4):c159-64. doi: 10.1159/000343564. Epub 2013 Jan 16.

PMID:
23327834
3.

High cut-off and high-flux membrane haemodialysis in a patient with rhabdomyolysis-associated acute kidney injury.

Albert C, Haase M, Bellomo R, Mertens PR.

Crit Care Resusc. 2012 Jun;14(2):159-62.

PMID:
22697626
4.

Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure.

Premru V, Kovač J, Buturović-Ponikvar J, Ponikvar R.

Ther Apher Dial. 2013 Aug;17(4):396-401. doi: 10.1111/1744-9987.12085.

PMID:
23931878
5.

Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure.

Wakabayashi Y, Kikuno T, Ohwada T, Kikawada R.

Intensive Care Med. 1994;20(2):109-12.

PMID:
8201089
6.

Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.

Ogungbenro K, Aarons L.

J Pharmacokinet Pharmacodyn. 2011 Apr;38(2):279-92. doi: 10.1007/s10928-011-9193-5. Epub 2011 Feb 24.

PMID:
21347679
7.

High cut-off membrane hemodiafiltration in myoglobinuric acute renal failure: a case series.

Premru V, Kovač J, Buturović-Ponikvar J, Ponikvar R.

Ther Apher Dial. 2011 Jun;15(3):287-91. doi: 10.1111/j.1744-9987.2011.00953.x.

PMID:
21624078
8.

Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.

Martín-Reyes G, Toledo-Rojas R, Torres-de Rueda Á, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, Martínez-Esteban MD, Díez-de los Ríos MJ, Bailén-García A, González-Molina M, García-González I.

Nefrologia. 2012;32(1):35-43. doi: 10.3265/Nefrologia.pre2011.Nov.11094. English, Spanish.

9.

Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney.

Grima DT, Airia P, Attard C, Hutchison CA.

Curr Med Res Opin. 2011 Feb;27(2):383-91. doi: 10.1185/03007995.2010.543125. Epub 2010 Dec 23.

PMID:
21175375
10.

Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.

Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.

Nephrol Dial Transplant. 2012 Oct;27(10):3823-8. doi: 10.1093/ndt/gfr773. Epub 2012 Jan 23.

PMID:
22273664
11.

Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.

Româo JE Jr, Fadil MA, Sabbaga E, Marcondes M.

Nephrol Dial Transplant. 1997 Jan;12(1):106-10.

PMID:
9027783
12.

DAISY: a new software tool to test global identifiability of biological and physiological systems.

Bellu G, Saccomani MP, Audoly S, D'Angiò L.

Comput Methods Programs Biomed. 2007 Oct;88(1):52-61. Epub 2007 Aug 20.

13.

[Middle molecules removal. Beyond beta2-microglobulin].

Maduell F, Sánchez-Canel JJ, Blasco JA, Navarro V, Ríus A, Torregrosa E, Pin MT, Cruz C, Ferrero JA.

Nefrologia. 2006;26(4):469-75. Spanish.

14.

Structural identifiability and indistinguishability analyses of the minimal model and a euglycemic hyperinsulinemic clamp model for glucose-insulin dynamics.

Chin SV, Chappell MJ.

Comput Methods Programs Biomed. 2011 Nov;104(2):120-34. doi: 10.1016/j.cmpb.2010.08.012. Epub 2010 Sep 18.

PMID:
20851494
15.

An iterative identification procedure for dynamic modeling of biochemical networks.

Balsa-Canto E, Alonso AA, Banga JR.

BMC Syst Biol. 2010 Feb 17;4:11. doi: 10.1186/1752-0509-4-11.

16.

Easy parameter identifiability analysis with COPASI.

Schaber J.

Biosystems. 2012 Dec;110(3):183-5. doi: 10.1016/j.biosystems.2012.09.003. Epub 2012 Oct 4.

PMID:
23041463
17.

Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role?

Miller CC 3rd, Villa MA, Sutton J, Lau D, Keyhani K, Estrera AL, Azizzadeh A, Coogan SM, Safi HJ.

Eur J Vasc Endovasc Surg. 2009 Apr;37(4):388-94. doi: 10.1016/j.ejvs.2008.12.020. Epub 2009 Feb 15.

18.

Theoretical approach and clinical application of kinetic modelling in dialysis.

Thews O, Deuber HJ, Hutten H, Schulz W.

Nephrol Dial Transplant. 1991;6(3):180-92.

PMID:
1866047
19.

Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis.

Maduell F, Navarro V, Cruz MC, Torregrosa E, Garcia D, Simon V, Ferrero JA.

Am J Kidney Dis. 2002 Sep;40(3):582-9.

PMID:
12200811
20.

Supplemental Content

Support Center